Click here to read this study in NEJM. ©2023 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
1. Redo-TAVR had low procedural complication rates and was comparable to native-TAVR in terms of risk of death and stroke ...
1. In patients with aortic stenosis undergoing transcatheter aortic valve replacement (TAVR), the use of cerebral embolic protection devices did ...
1. Among patients at intermediate surgical risk, transcatheter aortic valve replacement (TAVR) was shown to be noninferior to surgery with ...
1. Among all patients undergoing transcatheter aortic valve replacement, an increased risk of infective endocarditis was found in males, younger ...
1. The number and volume of new brain lesions was lower in patients with an implanted cerebral protection device following ...
1. Closure time with adenosine diphosphate (CT-ADP) measurement after a transcatheter aortic-valve replacement (TAVR) procedure was predictive of patients with ...
1. For intermediate-risk surgical candidates with aortic stenosis, transcatheter aortic-valve replacement (TAVR) was non-inferior to surgical aortic-valve replacement based on ...
1. In this secondary analysis of the PARTNER trial, women who underwent transcatheter aortic valve replacement (TAVR) had more major vascular complications, ...
1. One year after transcatheter aortic valve replacement (TAVR), the incidence of stroke was 4.1%, overall mortality was 23.7% and ...
